aclacinomycin has been researched along with dactinomycin in 2 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 19,045 | 355 | 969 |
| Protein | Taxonomy | aclacinomycin (IC50) | dactinomycin (IC50) |
|---|---|---|---|
| RAD51 | Homo sapiens (human) | 32.1 | |
| Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
| Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, O; Kudo, R; Takehara, M | 1 |
| Duverger, A; Jones, J; Kappes, J; Kutsch, O; Shishido, T; Wagner, F; Wolschendorf, F | 1 |
2 other study(ies) available for aclacinomycin and dactinomycin
| Article | Year |
|---|---|
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms | 1995 |
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.
Topics: Aclarubicin; Anti-HIV Agents; Cell Differentiation; Cell Line; Dactinomycin; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; T-Lymphocytes; Virus Activation; Virus Latency | 2012 |